TO THE POINT
  • 25 years of experience
  • MD from University of Virginia School of Medicine
  • Associate Director of the Brain Tumor and Neuro-Oncology Center at Cleveland Clinic (CC)
  • Serves at Cleveland Clinic’s Gamma Knife Center and the Lerner Research Institute’s Department of Cancer Biology
  • Associate Director of the Brain Tumor and Neuro-Oncology Center at CC
  • Director of the Center for Translational Therapeutics at CC
  • Has participated in numerous clinical trials relating to tumor-based cancers
  • Has co-authored more than 80 articles
  • Recipient of the American Association of Neurological Surgeons Young Clinician Investigator Award
  • Supported and funded by the American Cancer Society, the National Institutes of Health and the Wolf Family Foundation

Dr. Michael Vogelbaum, MD, PhD, FACS

Boardmember

Dr. Vogelbaum is the Associate Director of the Brain Tumor and Neuro-Oncology Center at Cleveland Clinic in Ohio. He has been a member of the professional staff at Cleveland Clinic since 1999. Dr. Vogelbaum specializes in the diagnosis and treatment of tumors of the brain and spinal cord. He has expertise in stereotactic and gama knife surgery as well as the molecular biology of brain tumors. Dr. Vogelbaum has additional joint appointments with the Cleveland Clinic’s Gamma Knife Center and the Lerner Research Institute’s Department of Cancer Biology. He is also Associate Director of the Brain Tumor and Neuro-Oncology Center and Director of the Center for Translational Therapeutics at Cleveland Clinic.

Dr. Vogelbaum has participated in several important clinical trials relating to the treatment and cure of cancer as it relates to gliomas and other tumor-based cancers. He has co-authored more than 80 articles and publications for the Neuro-Oncology community.

Dr. Vogelbaum is a graduate of the University of Virginia School of Medicine in Charlottesville, Virginia and received his specialty training in neurosurgery at the Barnes-Jewish Hospital in St. Louis, Missouri. Dr. Vogelbaum was the recipient of the prestigious American Association of Neurological Surgeons Young Clinician Investigator Award, and receives support and funding from the American Cancer Society, the National Institutes of Health and the Wolf Family Foundation.